James Morrison

baby is sitting in a crib and coughing

Child vaccination rates falling fast, with some regions barely reaching 80 per cent

By Peter Breadon, Grattan Institute and Mia Jessurun, Grattan Institute Child vaccination has been one of Australia’s biggest success stories. Before the COVID pandemic, we hit the national target of …

Systemic Failure: How Prisons Fail People who Inject Drugs and the Community

One in nine people in prisons globally have a history of injecting drug use and their risk of HIV, viral hepatitis and tuberculosis is up to 45 times higher than …

Stopping Hep E

A drug that is already in clinical trials against the hepatitis C virus (HCV) has been shown to be excellent at also preventing the hepatitis E virus (HEV) from replicating. …

New Australian Hepatitis Strategies Released

Australia has taken a significant step in its commitment to ending hepatitis B and C as public health challenges, with the launch of the Fourth National Hepatitis B Strategy 2025–2030 and …

10 Years of DAAs

Ten years ago, on 1 March 2016, Australia became the first country to publicly subsidise new direct-acting antiviral (DAA) hepatitis C treatments for the entire population, no matter their condition …

Can the hepatitis B virus’s genetic diversity predict its curability?

Scientists at Melbourne’s Doherty Institute are asking, “What if there was a way to predict which patients are more likely to achieve functional cure of chronic hepatitis B virus infection?” …

How Hepatitis B Became a Political Football

The illness and the damage in lives that will come from abandoning the hepatitis B birth dose vaccine is hard to overstate.

In Our Library: February 2026 Highlights

New additions to our Library: The healthy liver pantry, fatty liver disease, hepatitis and mental health, and more...

Hepatitis D Basics

There are five main hepatitis viruses, helpfully named A, B, C, D and E. The hepatitis D virus (HDV)—sometimes known as hepatitis delta—is relatively little-known because it can only live …

National Apology Day 2026

The Federal Government has committed $1.8 million over three years (starting in 2026) to continue the Hepatitis B Partnership Approach to Sustainably Eliminating Chronic Hepatitis B Project in the NT. …

Could New Hepatitis B Drug – Bepirovirsen – Offer a Higher Functional Cure Rate?

At the start of January, pharmaceutical company GSK announced positive results from its two phase-III trials for bepirovirsen, a potential first-in-class treatment for chronic hepatitis B. They claim that bepirovirsen …

Curing Hepatitis C Reduces Strain on the Immune System of HIV Patients

Fighting two infections at once puts an extra-heavy burden on the immune system. In Australia for example, a number of older people with haemophilia live with both hepatitis C and …

Abandoning Hepatitis B Vaccines for Babies is Bad Science and Bad Medicine

Hepatitis Australia, ASHM and the Australian Technical Group on Immunisation (ATAGI) are urging Australians to maintain routine hepatitis B vaccinations for newborns following the alarming news that the advisory panel …

Community Leaders Share Concerns About Hepatitis B and the Law

Hepatitis B is Australia’s most prevalent blood-borne virus, with nearly 220,000 people estimated to be living with chronic infection. In a recent report called ‘If Hepatitis was 100 People’, Hepatitis …

Treating Fibrosis with Henna

Henna is natural dye, orange-red in colour, made from the powdered leaves of Lawsonia inermis and was being used in body art, and as a dye for hair, nails and …

A Single-Dose Cure for Hep B?

Hepatitis B remains a global public health problem, even in countries like Australia with universal childhood vaccination. For people who have been infected, and who now live with chronic hepatitis B, …

Tasmania to pilot national hepatitis C awareness campaign

The Australian Government is funding a new hepatitis C awareness campaign to be piloted in Tasmania, as part of national efforts to identify and treat people who may be living with the …

UK Shows the Power of Opt-Out Testing

Thousands of Britons have been found to have been living with previously undiagnosed hepatitis and HIV under a new testing system recently introduced in accident and emergency departments by the …

Understanding Clinical Trials in MASLD

Involvement in a clinical trial may provide access to new treatments and provide participants with a higher level of clinical care, which many people with fatty liver find beneficial.

Pig-to-Human Liver Transplant Shows Mixed Success

Part of a liver from a genetically engineered pig has been transplanted into a living human recipient, who then survived a further six months before dying from repeated upper gastrointestinal …

My Health Record: BBV results now recorded by default

Recent changes to the processing of pathology reports for My Health Record has elevated the importance of pre-test counselling...

Cutting Out Hep B with ‘Molecular Scissors’

A genetic peculiarity that is sometimes found in biochemistry is ‘covalently closed circular DNA‘ (cccDNA), where the DNA molecule, instead of being a long, ribbon-like strand, becomes a closed loop. …

Hep C & Mental Illness: New Link Discovered

The blood–brain barrier is a hugely effective “wall” that protects the brain from pathogens in a person’s body. It’s like a highly selective, very fine sieve that allows vital nutrients …

How Hep B Research Helped when COVID-19 Hit

As the coronavirus spread globally in 2020, and people all around the world began to be uncomfortably familiar with RAT tests and PCR tests, NSW historian Michelle Bootcov realised her …